BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1377 related articles for article (PubMed ID: 12720118)

  • 21. Differential diagnosis of Waldenstrom's macroglobulinemia and other B-cell disorders.
    Pangalis GA; Kyrtsonis MC; Kontopidou FN; Siakantaris MP; Dimopoulou MN; Vassilakopoulos TP; Tzenou T; Kokoris S; Dimitriadou E; Kalpadakis C; Tsalimalma K; Tsaftaridis P; Panayiotidis P; Angelopoulou MK
    Clin Lymphoma; 2005 Mar; 5(4):235-40. PubMed ID: 15794855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders.
    Morra E; Cesana C; Klersy C; Barbarano L; Varettoni M; Cavanna L; Canesi B; Tresoldi E; Miqueleiz S; Bernuzzi P; Nosari AM; Lazzarino M
    Leukemia; 2004 Sep; 18(9):1512-7. PubMed ID: 15322559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
    Treon SP; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Sheehy P; Manning RJ; Patterson CJ; Tripsas C; Arcaini L; Pinkus GS; Rodig SJ; Sohani AR; Harris NL; Laramie JM; Skifter DA; Lincoln SE; Hunter ZR
    N Engl J Med; 2012 Aug; 367(9):826-33. PubMed ID: 22931316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD20-directed antibody-mediated immunotherapy induces responses and facilitates hematologic recovery in patients with Waldenstrom's macroglobulinemia.
    Treon SP; Agus TB; Link B; Rodrigues G; Molina A; Lacy MQ; Fisher DC; Emmanouilides C; Richards AI; Clark B; Lucas MS; Schlossman R; Schenkein D; Lin B; Kimby E; Anderson KC; Byrd JC
    J Immunother; 2001; 24(3):272-9. PubMed ID: 11394506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Asymptomatic Waldenstrom's macroglobulinemia.
    Alexanian R; Weber D; Delasalle K; Cabanillas F; Dimopoulos M
    Semin Oncol; 2003 Apr; 30(2):206-10. PubMed ID: 12720137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiparameter flow cytometry for the identification of the Waldenström's clone in IgM-MGUS and Waldenström's Macroglobulinemia: new criteria for differential diagnosis and risk stratification.
    Paiva B; Montes MC; García-Sanz R; Ocio EM; Alonso J; de Las Heras N; Escalante F; Cuello R; de Coca AG; Galende J; Hernández J; Sierra M; Martin A; Pardal E; Bárez A; Alonso J; Suarez L; González-López TJ; Perez JJ; Orfao A; Vidríales MB; San Miguel JF
    Leukemia; 2014 Jan; 28(1):166-73. PubMed ID: 23604227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Waldenström macroglobulinaemia.
    Fonseca R; Hayman S
    Br J Haematol; 2007 Sep; 138(6):700-20. PubMed ID: 17672883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's Macroglobulinemia.
    Dimopoulos MA; Gertz MA; Kastritis E; Garcia-Sanz R; Kimby EK; Leblond V; Fermand JP; Merlini G; Morel P; Morra E; Ocio EM; Owen R; Ghobrial IM; Seymour J; Kyle RA; Treon SP
    J Clin Oncol; 2009 Jan; 27(1):120-6. PubMed ID: 19047284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiogenesis in Waldenström's macroglobulinemia.
    Terpos E; Tasidou A; Kastritis E; Eleftherakis-Papaiakovou E; Gavriatopoulou M; Migkou M; Dimopoulos MA
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):46-9. PubMed ID: 19362971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostics in Waldenström's macroglobulinemia: a consensus statement of the European Consortium for Waldenström's Macroglobulinemia.
    Dogliotti I; Jiménez C; Varettoni M; Talaulikar D; Bagratuni T; Ferrante M; Pérez J; Drandi D; Puig N; Gilestro M; García-Álvarez M; Owen R; Jurczak W; Tedeschi A; Leblond V; Kastritis E; Kersten MJ; D'Sa S; Kaščák M; Willenbacher W; Roccaro AM; Poulain S; Morel P; Kyriakou C; Fend F; Vos JMI; Dimopoulos MA; Buske C; Ferrero S; García-Sanz R
    Leukemia; 2023 Feb; 37(2):388-395. PubMed ID: 36435884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant transformation in IgM monoclonal gammopathy of undetermined significance.
    Montoto S; Rozman M; Rosiñol L; Nadal E; Giné E; Aymerich M; Ferrer A; Esteve J; Bosch F; López-Guillermo A; Bladé J; Montserrat E
    Semin Oncol; 2003 Apr; 30(2):178-81. PubMed ID: 12720132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Origins of the malignant clone in typical Waldenstrom's macroglobulinemia.
    Sahota SS; Forconi F; Ottensmeier CH; Stevenson FK
    Semin Oncol; 2003 Apr; 30(2):136-41. PubMed ID: 12720123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Familial Waldenstrom's macroglobulinemia.
    McMaster ML
    Semin Oncol; 2003 Apr; 30(2):146-52. PubMed ID: 12720125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors and indications for treatment of Waldenström's Macroglobulinemia.
    Kyle RA; Ansell SM; Kapoor P
    Best Pract Res Clin Haematol; 2016 Jun; 29(2):179-186. PubMed ID: 27825464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological correlates of IgM paraproteinemias.
    Owen RG; Parapia LA; Higginson J; Misbah SA; Child JA; Morgan GJ; Jack AS
    Clin Lymphoma; 2000 Jun; 1(1):39-43; discussion 44-5. PubMed ID: 11707811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunophenotypic profile of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia.
    Konoplev S; Medeiros LJ; Bueso-Ramos CE; Jorgensen JL; Lin P
    Am J Clin Pathol; 2005 Sep; 124(3):414-20. PubMed ID: 16191510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal gammopathy of undetermined significance and Waldenström's macroglobulinemia.
    Mailankody S; Landgren O
    Best Pract Res Clin Haematol; 2016 Jun; 29(2):187-193. PubMed ID: 27825465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IgM monoclonal gammopathy/Waldenström's macroglobulinemia: a morphological and immunophenotypic study of the bone marrow.
    Feiner HD; Rizk CC; Finfer MD; Bannan M; Gottesman SR; Chuba JV; Amorosi E
    Mod Pathol; 1990 May; 3(3):348-56. PubMed ID: 2114024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment of an animal model for Waldenström's macroglobulinemia.
    Tsingotjidou AS; Emmanouilides CE; Siotou E; Poutahidis T; Xagorari A; Loukopoulos P; Sotiropoulos D; Bekiari C; Doulberis M; Givissis P; Fassas A; Anagnostopoulos A
    Exp Hematol; 2009 Apr; 37(4):469-76. PubMed ID: 19302921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The malignant clone in Waldenstrom's macroglobulinemia.
    Kriangkum J; Taylor BJ; Mant MJ; Treon SP; Belch AR; Pilarski LM
    Semin Oncol; 2003 Apr; 30(2):132-5. PubMed ID: 12720122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 69.